Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States.

Palmer, Cynthia S; Nuijten, Mark J C; Schmier, Jordana K; Subedi, Prasun; Snyder, Edward H

Palmer, Cynthia S; Nuijten, Mark J C; Schmier, Jordana K; Subedi, Prasun; Snyder, Edward H.

Affiliation

Palmer CS; MEDTAP International, Bethesda, Maryland, USA.

Pharmacoeconomics ; 20(9): 617-28, 2002.

Article in En | MEDLINE | ID: mdl-12141889

Subject(s)

Antiparkinson Agents/administration & dosage; Catechols/administration & dosage; Health Care Costs/statistics & numerical data; Levodopa/administration & dosage; Parkinson Disease/drug therapy; Parkinson Disease/economics; Quality-Adjusted Life Years; Aged; Antiparkinson Agents/economics; Catechols/economics; Cost-Benefit Analysis; Drug Costs/statistics & numerical data; Drug Therapy, Combination; Humans; Levodopa/economics; Markov Chains; Nitriles; Patient Satisfaction; Treatment Outcome; United States

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Levodopa / Catechols / Health Care Costs / Quality-Adjusted Life Years / Antiparkinson Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Humans Country/Region as subject: America do norte Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2002 Document type: Article Affiliation country: United States Country of publication: New Zealand

Search on Google

Add to My VHL

XML

PubMed Links